Cip/Kip cell-cycle inhibitors: A neuro-oncological perspective

Citation
Tg. Mainprize et al., Cip/Kip cell-cycle inhibitors: A neuro-oncological perspective, J NEURO-ONC, 51(3), 2001, pp. 205-218
Citations number
152
Categorie Soggetti
Oncology
Journal title
JOURNAL OF NEURO-ONCOLOGY
ISSN journal
0167594X → ACNP
Volume
51
Issue
3
Year of publication
2001
Pages
205 - 218
Database
ISI
SICI code
0167-594X(200102)51:3<205:CCIANP>2.0.ZU;2-V
Abstract
The cell cycle is a precisely controlled cellular program that ensures norm al cellular proliferation and development. The cyclin-dependant kinases (CD K) are molecules central to the continued progression through the cell-cycl e checkpoints and as such are regulated by various mechanisms including cyc lin levels, phosphorylation/dephosphorylation and cyclin-dependant kinase i nhibitors (CKI). The CKIs are grouped into two families based on their stru cture and function, four Ink4 CKIs and three Cip/Kip CKIs. Abnormalities in these proteins can give rise to developmental defects and cancer. In this review, we will discuss the biochemistry and cell biology of the each of th e Cip/Kip CKIs, their role in development as evidenced by targeted mutation s in mice, and their role as possible tumor suppressor genes.